Home/Filings/4/0001415889-25-018748
4//SEC Filing

Singh Shawn 4

Accession 0001415889-25-018748

CIK 0001411685other

Filed

Jun 30, 8:00 PM ET

Accepted

Jul 1, 5:48 PM ET

Size

5.8 KB

Accession

0001415889-25-018748

Insider Transaction Report

Form 4
Period: 2025-06-30
Singh Shawn
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Award

    Common Stock

    2025-06-30$1.70/sh+7,541$12,82018,028 total
Holdings
  • Common Stock

    (indirect: By Trust)
    20,875
Footnotes (1)
  • [F1]The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d).

Issuer

Vistagen Therapeutics, Inc.

CIK 0001411685

Entity typeother

Related Parties

1
  • filerCIK 0001412071

Filing Metadata

Form type
4
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 5:48 PM ET
Size
5.8 KB